EcoDrugPlus

Integrin Beta 3a

Ensembl ID : ENSACIG00000009658
Gene Symbol: ITGB3A
1 Cross references
204 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSACIG00000010076
Gene Symbol: ITGB3B
1 Cross references
195 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSACIG00000020177
Gene Symbol: ITGA4
1 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSACIG00000019658
Gene Symbol: ITGA5
1 Cross references
196 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSACIG00000000115
Gene Symbol: ITGB6
1 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSACIG00000020344
Gene Symbol: ITGB8
1 Cross references
207 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSACIG00000017547
Gene Symbol: ITGA2B
1 Cross references
191 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSACIG00000014031
Gene Symbol: ITGA5
1 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSACIG00000005701
Gene Symbol: ITGAV
1 Cross references
238 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSACIG00000009579
Gene Symbol: ITGB1A
1 Cross references
209 Possible Orthologues:

Integrin, Beta 1b

Ensembl ID : ENSACIG00000000337
Gene Symbol: ITGB1B
1 Cross references
230 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSACIG00000017881
Gene Symbol: ITGB5
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).